ImmunityBio converts from Immunomedics | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
ImmunityBio converts from Immunomedics

An SI Board Since February 2023

Posts	SubjectMarks	Bans	Symbol
1518	51	0	IBRX

Emcee: TinfoilHat	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
635	Couldn’t hurt.	jargonweary	-	9/6/2024
634	What do people think would happen if at the Sep 9 meeting PSS or Adcock were to	bobbseytwins2001	2	9/6/2024
633	I only have a vague suspicion about what is going on with the stock price declin	jargonweary	3	9/6/2024
632	Well I’m back in the saddle again and bought back in this morning! There’s a big	Redman1234	-	9/6/2024
631	Me think you take matters a bit too far {eom} I've only heard about PSS thr	waitwatchwander	-	9/6/2024
630	No, it could not be that simple. If it were, there would NEVER be any analysts	Fitzhughlaw	1	9/6/2024
629	He doesn't want to get sued nor create opportunities on that front. Too dis	waitwatchwander	-	9/6/2024
628	Again, your reply misses the point, because you again focus on a granular item (	Fitzhughlaw	2	9/6/2024
627	Negotiating a partnership takes time. I’m assuming there are offers with differe	Redman1234	2	9/6/2024
626	"I’m not sure why anyone would expect a PR before the conference and defini	Fitzhughlaw	3	9/6/2024
625	First I’ll be honest and say I had sold my shares at a small loss a little while	Redman1234	-	9/6/2024
624	Even Tinfoil Hat can't make this look good. Everything here indicates winni	bobbseytwins2001	5	9/5/2024
623	It's been three weeks since this topic was raised and discussed as per the e	Fitzhughlaw	5	9/5/2024
622	From Chat GPT 4.0 on the Abstract: The abstract presents promising data regardi	End2War	6	8/27/2024
621	From abstract at redmans link IL15 Superagonist (N-803, Anktiva) + Checkpoint	erippetoe	5	8/20/2024
620	From ST board. Sept 8th. NSCLC abstract. stkt.co	Redman1234	1	8/20/2024
619	I think too much is being read into this, and there’s a simple reason why the SP	Redman1234	4	8/19/2024
618	Gotta be the cash burn problem. I, too, am disappointed by this. I’m getting th	galt	1	8/19/2024
617	Does anyone know Catanzaro's rationale for a $4.75 price target? Are we all	bobbseytwins2001	1	8/19/2024
616	Just an FYI: weakness today probably due to: Piper Sandler analyst Joseph Cata	luckydog88	-	8/19/2024
615	Merck signed a big licensing agreement with Daiichi for their ADC pipeline. ADC	TinfoilHat	4	8/19/2024
614	Merck needs Anktiva desperately. Every attempt to extend the patent on Keytruda	ghettogoulash	-	8/19/2024
613	Far be it from me to take the under, but here you go: I don't think a confe	TinfoilHat	5	8/13/2024
612	Ha ha. Agree totally. Very sophomoric, at best. I too bought more today, adding	galt	-	8/13/2024
611	Ha looks like you are spending too much time on stocktwits like me! I need to st	sukit	3	8/13/2024

Go to reply# or date (mm/dd/yy):